Midaxifylline
Alternative Names: IRFI 117; IRFI 117BBLatest Information Update: 04 May 2007
At a glance
- Originator Biomedica Foscama
- Class Antipsychotics; Neuroprotectants
- Mechanism of Action Adenosine A1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Cardiovascular disorders; Kidney disorders; Major depressive disorder
Most Recent Events
- 20 Oct 2005 Suspended - Preclinical for Cardiovascular disorders in Italy (unspecified route)
- 20 Oct 2005 Suspended - Preclinical for Kidney disorders in Italy (unspecified route)
- 19 Feb 2003 No development reported - Preclinical for Cardiovascular disorders in Italy (unspecified route)